Literature DB >> 7105401

N-acetyl beta-D-glucosaminidase and alpha-L-fucosidase activities in relation to glycosylated hemoglobin levels and to retinopathy in diabetes.

J M Miralles, J J Corrales, L C Garcia-Diez, J A Cabezas, A Reglero.   

Abstract

N-Acetyl beta-D-glucosaminidase and alpha-L-fucosidase were determined in human sera from 25 control subjects, in 23 diabetic patients without retinopathy and in 22 diabetic patients with retinopathy. The results show significantly higher N-acetyl beta-D-glucosaminidase activity in diabetic patients independently of the development of retinopathy and also independently of the length of diabetes. No correlation was found between either serum enzymes and serum glucose concentration and glycosylated hemoglobin (HbA1).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7105401     DOI: 10.1016/0009-8981(82)90246-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  Serum beta-N-acetyl hexosaminidase and bile acid levels in patients with benign and malignant biliary obstruction.

Authors:  E Scapa; B H Novis; M Loewenstein; P Thomas; N Zamcheck
Journal:  Dig Dis Sci       Date:  1988-02       Impact factor: 3.199

2.  Serum enzymes of lysosomal origin as indicators of the metabolic control in non-insulin-dependent diabetics.

Authors:  G Goi; A Lombardo; A Fabi; A B Burlina; G Segalini; E Guagnellini; G Tettamanti
Journal:  Acta Diabetol Lat       Date:  1987 Oct-Dec

3.  Increased serum N-acetyl-beta-D-glucosaminidase and alpha-D-mannosidase activities in obese subjects.

Authors:  J Corral; J M Miralles; I J García-Pascual; J J Corrales; A García-Sastre; E Villar
Journal:  Clin Investig       Date:  1992-10

4.  Serum enzymes of lysosomal origin as indicators of the metabolic control in diabetes: comparison with glycated hemoglobin and albumin.

Authors:  G Goi; A Fabi; R Lorenzi; A Lombardo; G Tettamanti; A B Burlina; L Pinelli; D Gaburro
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.